• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDELA LLC PUMP IN STYLE MANAGED MARKETS EN FR ES (YELLOWFIN); PUMP, BREAST, POWERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDELA LLC PUMP IN STYLE MANAGED MARKETS EN FR ES (YELLOWFIN); PUMP, BREAST, POWERED Back to Search Results
Model Number 101041360
Health Effect - Clinical Codes Bacterial Infection (1735); Pain (1994)
Date of Event 01/23/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Customer service conducted troubleshooting including verifying the breast shield size.The customer was sent larger size breast shields and return of her breast shields was requested for testing/analyzing.The customer was contacted by a complaint handler on multiple occasions, including in writing, to get additional information, with no response as of the date of this report.Based on the results of our internal investigation (reference number (b)(4)), it cannot be definitively concluded that the pump caused or contributed to the customer¿s mastitis.The estimated incidence of mastitis in lactating women, whether using a breast pump or not, according to published clinical literature can be as high as 33%.In fact, clinical guidelines suggest the use of a breast pump to facilitate withdrawal of breast milk during bouts of mastitis.The complaint rate of mastitis across all reported failures, across all medela breast pumps, is 0.008% for the period of january 2013 to august 2017.Mastitis is usually a benign, self-limiting infection with few consequences for the suckling infant.The risk of mastitis is higher among women who have breastfed previously, especially those with a history of mastitis.Riordan & wambach, 4th ed.P.294: breastfeeding and human lactation.However, in this case, the mother¿s mastitis required prompt medical attention for pain relief and prescription antibiotics to avoid progression to overwhelming sepsis.
 
Event or Problem Description
On (b)(6) 2023, the customer alleged to medela llc that she was experiencing pain while using her pump in style max flow breast pump.She additionally alleged that she has mastitis and was very sore.She is taking an antibiotic.
 
Additional Manufacturer Narrative
The device was returned with the customer's parts and accessories and was evaluated on 02/08/2023.The device passed suction and cycle specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PUMP IN STYLE MANAGED MARKETS EN FR ES (YELLOWFIN)
Common Device Name
PUMP, BREAST, POWERED
Manufacturer (Section D)
MEDELA LLC
1101 corporate dr
mchenry IL 60050
Manufacturer (Section G)
MEDELA LLC
1101 corporate dr
mchenry IL 60050
Manufacturer Contact
dave kurudza
1101 corporate drive
mchenry, IL 60050
8004358316
MDR Report Key16291263
Report Number1419937-2023-00008
Device Sequence Number5020209
Product Code HGX
UDI-Device Identifier00020451401447
UDI-Public020451401447
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K200508
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number101041360
Device Catalogue Number101041360
Device Lot Number0000330857
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Distributor Facility Aware Date01/23/2023
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 01/23/2023
Supplement Date Received by Manufacturer02/08/2023
Initial Report FDA Received Date02/03/2023
Supplement Report FDA Received Date02/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured11/10/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-